A test carried out during weeks 15-20 of the pregnancy, in which a small amount of the fluid that surrounds the fetus is removed for biochemical or genetic testing. It can assess whether the fetus could develop, or has developed, an abnormality or serious health condition.
Prenatal genetic test results need to be communicated better, according to the US Food and Drug Administration...
A single blood drop, taken without your consent, can be life-changing...
A long-running court case over non-invasive prenatal testing patents has been settled...
Non-invasive prenatal testing (NIPT) was first introduced in 2011, when breakthroughs in sequencing technology allowed the analysis of cell-free fetal DNA (cffDNA) in maternal blood to detect genetic abnormalities in the foetus, such as trisomy 21 (Down
Jnetics and Chana shared their first joint event, with leading experts speaking about Jewish genetic disorder carrier screening, fertility advice and the reproductive options available to ensure genetic disorders are not passed onto future children...
The TedMed talk by Professor Alta Charo, entitled 'Should we fear gene editing?', highlights the progress made and the concerns raised in genetic research over the past fifty years...
The UK Patents Court has ruled that two separate non-invasive prenatal tests infringe patents licensed by the US firm Illumina...
The new 'reflex' method of antenatal screening for Down's, Edwards' and Patau's syndromes was described last week as a 'transformational advance'. It might be cheaper than other approaches, but it could come at the cost of informed choice for pregnant wom
Non-invasive pre-natal screening for certain abnormalities in fetal chromosomes should be offered to at-risks mothers, recommends the American College of Obstetricians and Gynecologists...
A new method for prenatal testing for Down's syndrome will be tried out at Great Ormond Street Hospital for Children (GOSH), London....
